Oncology
5 drugs are in development for Mesothelioma.
- Companies
- 3
- Clinical trials
- 24
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Mesothelioma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(2)
| Drug | Company |
|---|---|
| CTX-471 | Compass Therapeutics, Inc. (CMPX) |
| IDE397 | IDEAYA Biosciences, Inc. (IDYA) |
Phase 1/Phase 2(3)
About this indication
Mesothelioma context
Oncology·MeSH: Mesothelioma (D008654)
Also known as: Mesotheliomas
Prevalence
1.0 / 100K
Incidence
0.9 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Mesothelioma?
BioSniper tracks 5 drugs in development for Mesothelioma across 3 companies.
How many clinical trials target Mesothelioma?
There are 24 clinical trials targeting Mesothelioma tracked by BioSniper.
What is the prevalence of Mesothelioma?
The estimated prevalence of Mesothelioma is approximately 1.0 per 100,000 population.